GENEVA, May 12 -- 3Z PHARMACEUTICALS (Menntavegur 1101 Reykjavik) filed a patent application (PCT/EP2024/080948) for "USE OF A CALCIUM CHANNEL BLOCKER IN THE TREATMENT OF ADHD" on Nov 01, 2024. With publication no. WO/2025/093748, the details related to the patent application was published on May 08, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): KARLSSON, Karl AEgir (c/o 3Z EHFMenntavegur 1101 Reykjavik), PORSTEINSSON, Haraldur (c/o 3Z EHFMenntavegur 1101 Reykjavik)
Abstract:
The present invention provides cilnidipine, nilvadipine, isradipine, felodipine, verapamil, nimodipine or nifedi...